PrimeVigilance

PrimeVigilance, established in 2008 and based in the United Kingdom, is a specialized provider of safety services for the pharmaceutical, generic, and biotechnology sectors. Operating within the Management Consulting and Business Services industries, the company focuses on delivering comprehensive pharmacovigilance solutions. Its product portfolio includes medical information services, integrated risk management, and regulatory affairs support, designed to ensure high-quality, responsible operations for its clients. With a significant global presence, PrimeVigilance serves a diverse clientele requiring expert handling of safety data and compliance.

The company operates with an employee range of 500 - 1,000 individuals and manages operations across 33 locations, indicating a substantial operational footprint. PrimeVigilance offers integrated international, multi-language services, emphasizing quality and efficiency in case processing and safety surveillance. For insights into the people driving these operations, you can Meet PrimeVigilance's team. Their expertise spans critical areas such as clinical safety, regulatory compliance, and medical information management, supporting clients through complex global health landscapes.

PrimeVigilance competes in a dynamic market against firms like Kinapse, Quotient Sciences, and IQVIA Biotech, highlighting its position among established industry players. The company's revenue stands at $153.7M, reflecting its market scale and service delivery capacity. Its strategic focus on pharmacovigilance and related safety services positions it as a key partner for life sciences companies navigating stringent regulatory environments and seeking robust risk management frameworks. The company's extensive product offerings underscore its commitment to comprehensive safety and regulatory support.